Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Intangibles (2025)

China Pharma Holdings' Change in Intangibles history spans 6 years, with the latest figure at $5313.0 for Q4 2025.

  • For Q4 2025, Change in Intangibles changed N/A year-over-year to $5313.0; the TTM value through Dec 2025 reached $77927.0, changed N/A, while the annual FY2025 figure was $77927.0, 69.24% down from the prior year.
  • Change in Intangibles reached $5313.0 in Q4 2025 per CPHI's latest filing, down from $39987.0 in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $39987.0 in Q3 2025 to a low of $5313.0 in Q4 2025.